Race Oncology (ASX:RAC) has completed its Phase 1b/2 trial of bisantrene in combination with clofarabine and fludarabine for ...
Kyverna Therapeutics, Inc. (Kyverna), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell ...
The RSC and 37 other organisations have signed a letter to Chancellor Rachel Reeves that reiterates the long-term social and economic benefits of R&D activity in the UK. David Baker, Demis Hassabis ...